Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
GMAB
$28.67
-0.97%
Analyze
1M
-2.3%
3M
+24.2%
1Y
+23.9%
Market Cap:
$17.63B
Genmab AS
N/A |
N/A
Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark.
Click "Analyze" to generate stock analysis
GMAB Price Trend and Signals
GMAB Option Volumes & Open Interests (aggregated)
GMAB Put Call Ratios and IV (aggregated)
GMAB Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-30
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-29
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-27
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-13
Somewhat Bearish
macd_signal
Dead cross above zero detected.